Regeneron Stock Up 19.7% After Positive VEGF Trap-Eye Report Nov. 23, 2010 By Tom Wall No Comments The talk from Regeneron Pharmaceuticals Inc. is of trials – clinical and, perhaps, legal. (BioWorld Today)Read More
Sekisui Buys Genzyme's Diagnostic Unit for $265M Nov. 19, 2010 By Tom Wall No Comments It was biotech's version of "buy-one-get-one" for Genzyme business units on Thursday. (BioWorld Today)Read More
